Ranked #5 in the nation by U.S. News & World Report
A genetic disease that results in the formation of thick mucus in the airways, cystic fibrosis (CF) causes patients to experience severe difficulty with digestive and respiratory functions. Some 70,000 people worldwide suffer from cystic fibrosis, and millions unknowingly carry the defective CF gene.
Duke continues to advance the diagnosis and treatment of cystic fibrosis, and has contributed to the marked improvement in the quality and quantity of life for patients in recent years.
Certified by the Cystic Fibrosis Foundation, the Duke Cystic Fibrosis Clinic cares for both inpatients and outpatients suffering from every degree of CF.
We are staffed by a multidisciplinary team that includes pulmonologists and critical care specialists, nurse practitioners, respiratory therapists, nutritionists, social workers, and a pharmacist.
Duke's internationally recognized lung transplantation program has been highly successful in treating CF patients, particularly those with antibiotic-resistant lung infections. We partner with pharmaceutical companies and other institutions to develop combinations of existing and experimental drugs to treat infections and prevent them from affecting the transplanted lungs.
In addition, our clinicians work closely with Duke researchers in an effort to better understand, treat, and eventually cure CF. Improvements in antibiotics, drug-delivery systems, and pulmonary rehabilitation, as well as recent strides in genetic technology, show great promise for cystic fibrosis patients and those who carry the CF gene.
To learn more about the Duke Cystic Fibrosis Clinic, or to schedule an appointment or get a referral, call 919-668-7630 locally or 888-ASK-DUKE (888-275-3853) toll-free.
Physicians offering this service include:
This service is available at: